Filing Details

Accession Number:
0001114220-18-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-31 16:20:56
Reporting Period:
2018-05-29
Accepted Time:
2018-05-31 16:20:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398422 J Kevin Cameron C/O Keryx Biopharmaceuticals, Inc.
One Marina Park Drive, 12Th Floor
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-05-29 1,667 $5.22 168,333 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of a total of 1,667 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017.
  2. Includes 16,666 shares of restricted stock.